| Literature DB >> 31039787 |
Ali Salami1, Hadi Fakih2, Mohamed Chakkour3, Lamis Salloum4, Hisham F Bahmad5,6, Ghassan Ghssein7.
Abstract
BACKGROUND: Acute gastroenteritis (AGE) is a major cause of pediatric morbidity and mortality around the world. It remains a frequent reason for infection-related admissions to emergency units among all age groups. Following the Syrian refugee crisis and insufficient clean water in our region, we sought to assess the etiological and epidemiological factors pertaining to AGE in South Lebanon.Entities:
Keywords: Acute gastroenteritis; E. histolytica; Lebanon; Pediatric; Unidentified enteropathogens
Mesh:
Substances:
Year: 2019 PMID: 31039787 PMCID: PMC6489254 DOI: 10.1186/s12887-019-1513-8
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Fig. 1Number of acute gastroenteritis patients according to the month of admission
Demographic characteristics of patients among the five studied groups
| Demographic Characteristics | Unidentified group I n/N (%) | Mixed group V n/N (%) | Total GE N | ||||
|---|---|---|---|---|---|---|---|
| Age (months) |
| ||||||
| 1–3 | 28/52 (53.8%) | 5/52 (9.6%) | 16/52 (30.8%) | 2/52 (3.8%) | 1/52 (1.9%) | 52 | |
| 4–11 | 74/178 (41.6%) | 26/178 (14.6%) | 50/178 (28.1%) | 12/178 (6.7%) | 16/178 (9.0%) | 178 | |
| 12–23 | 76/168 (45.2%) | 26/168 (15.5%) | 46/168 (27.4%) | 7/168 (4.2%) | 13/168 (7.7%) | 168 | |
| 24–35 | 50/94 (53.2%) | 11/94 (11.7%) | 22/94 (23.4%) | 9/94 (9.6%) | 2/94 (2.1%) | 94 | |
| 36–47 | 26/57 (45.6%) | 12/57 (21.1%) | 11/57 (19.3%) | 7/57 (12.3%) | 1/57 (1.8%) | 57 | |
| 48–60 | 33/69 (47.8%) | 4/69 (5.8%) | 27/69 (39.1%) | 1/69 (1.4%) | 4/69 (5.8%) | 69 | |
| Total | 287 | 84 | 172 | 38 | 37 | 618 | |
| Gender | 0.250 | ||||||
| Female | 111/266 (38.7%) | 36/266 (42.9%) | 85/266 (49.4%) | 16/266 (42.1%) | 18/266 (47.4%) | 266 | |
| Male | 176/353 (61.3%) | 48/353 (57.1%) | 87/353 (50.6%) | 22/353 (57.9%) | 20/353 (52.6%) | 353 | |
| Total | 287 | 84 | 172 | 38 | 38 | 619 | |
| Breast feeding | 0.094 | ||||||
| No | 84/175 (48.0%) | 25/175 (14.3%) | 36/175 (20.6%) | 15/175 (8.6%) | 15/175 (8.6%) | 175 | |
| Yes | 169/381 (44.4%) | 55/381 (14.4%) | 115/381 (30.2%) | 20/381 (5.2%) | 22/381 (5.8%) | 381 | |
| Total | 253 | 80 | 151 | 35 | 37 | 556 | |
| Rotavirus vaccine |
| ||||||
| No | 108/256 (42.2%) | 53/256 (20.7%) | 66/256 (25.8%) | 7/256 (2.7%) | 22/256 (8.6%) | 256 | |
| Yes | 142/295 (48.1%) | 27/295 (9.2%) | 84/295 (28.5%) | 27/295 (9.2%) | 15/295 (5.1%) | 295 | |
| Total | 250 | 80 | 150 | 34 | 37 | 551 | |
| Sanitary water | 0.333 | ||||||
| No | 70/146 (47.9%) | 15/146 (10.3%) | 41/146 (28.1%) | 13/146 (8.9%) | 7/146 (4.8%) | 146 | |
| Yes | 217/473 (45.9%) | 69/473 (14.6%) | 131/473 (27.7%) | 25/473 (5.3%) | 31/473 (6.6%) | 473 | |
| Total | 287 | 84 | 172 | 38 | 38 | 619 | |
| Housewife mothers | 0.843 | ||||||
| No | 187/413 (45.3%) | 56/413 (13.6%) | 114/413 (27.6%) | 27/413 (6.5%) | 29/413 (7.0%) | 413 | |
| Yes | 67/144 (46.5%) | 24/144 (16.7%) | 37/144 (25.7%) | 8/144 (5.6%) | 8/144 (5.6%) | 144 | |
| Total | 254 | 80 | 151 | 35 | 37 | 557 | |
| Mean Family size | 4.02 | 4.45 | 4.04 | 3.64 | 4.34 | 4.1a |
|
aMean of the five groups; significant p-values are made bold
Fig. 2Percentage of cases of each enteropathogen according to the month of admission
Clinical and laboratory data of patients
| Clinical Characteristics | Unidentified group I | Mixed group V | Total | ||||
|---|---|---|---|---|---|---|---|
| Frequency (%) | 287 (46.4%) | 84 (13.6%) | 172 (27.8%) | 38 (6.1%) | 38 (6.1%) | 619 | – |
| Clinical Manifestations | |||||||
| Fever | 215 (74.9%) | 52 (61.9%) | 143 (83.1%) | 22 (57.9%) | 26 (68.4%) | 458 |
|
| Vomiting | 112 (39.0%) | 53 (63.1%) | 66 (38.4%) | 22 (57.9%) | 24 (63.2%) | 277 |
|
| Diarrhea | 208 (72.5%) | 69 (82.1%) | 144 (83.7%) | 33 (86.8%) | 29 (76.3%) | 483 |
|
| Vesikari score (Mean ± SD) | 11.2 ± 1.8 | 11.4 ± 1.5 | 11.8 ± 1.6 | 11.2 ± 1.6 | 11.3 ± 1.8 | – |
|
| Duration of hospitalization per days (Mean ± SD) | 2.7 ± 1.2 | 2.9 ± 1.1 | 2.9 ± 1.2 | 3.3 ± 2.1 | 3.4 ± 1.3 | 3.04a |
|
| Laboratory Findings | |||||||
| WBCs (× 103 per mm3) | 2.79 ± 3.85 | 2.29 ± 3.04 | 12.23 ± 4.98 | 1.92 ± 2.29 | 7.15 ± 6.76 | – |
|
| RBCs (million per mm3) | 1.47 ± 1.88 | 1.53 ± 2.06 | 7.10 ± 5.45 | 1.14 ± 1.01 | 3.19 ± 3.99 | – |
|
| HGB (in mg/dL; mean ± SD) | 11.7 ± 2.4 | 11.5 ± 1.2 | 12.6 ± 8.4 | 12.1 ± 1.0 | 11.5 ± 1.1 | – |
|
| HCT (in %; mean ± SD) | 33.5 ± 4.1 | 33.9 ± 3.2 | 34.0 ± 4.2 | 34.8 ± 4.7 | 34.1 ± 2.9 | – |
|
| BS (in mg/dL; mean ± SD) | 91.1 ± 28.3 | 77.1 ± 20.1 | 97.5 ± 19.2 | 86.0 ± 27.7 | 87.3 ± 19.1 | – |
|
| CRP (in mg/dL; mean ± SD) | 49.5 ± 65.9 | 28.0 ± 61.4 | 66.3 ± 67.4 | 11.7 ± 20.0 | 43.7 ± 85.9 | – |
|
Abbreviations: WBCs White blood cells, RBCs Red blood cells, HGB Hemoglobin, HCT Hematocrit, BS Blood sugar, CRP C-reactive protein
aMean of the five groups; significant p-values are made bold
Results of the logistic regression analysis with infectious agents as dependent variables according to breast-feed, Rota-vaccine, and sanitary water
| Independent variables | Unidentified group I | Mixed group V | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Breast-feed* | 0.866 | 0.606- | 1.013 | 0.608- | 1.668 | 1.089- | 0.592 | 0.295- | 0.655 | 0.331- |
| 0.431 | 1.238 | 0.959 | 1.688 |
| 2.555 | 0.139 | 1.185 | 0.223 | 1.294 | |
| Rotavirus vaccine* | 1.224 | 0.875- | 0.377 | 0.229- | 1.114 | 0.765- | 3.505 | 1.500- | 0.558 | 0.283- |
| 0.238 | 1.712 |
| 0.621 | 0.573 | 1.624 |
| 8.191 | 0.092 | 1.100 | |
| Sanitary water* | 0.930 | 0.643- | 1.500 | 0.830- | 0.988 | 0.654- | 0.574 | 0.286- | 1.400 | 0.603- |
| 0.700 | 1.346 | 0.180 | 2.710 | 0.955 | 1.92 | 0.119 | 1.153 | 0.433 | 3.249 | |
*Reference groups: Breast-feed (Yes), Rota-vaccine (Yes), and Sanitary water (Yes); significant p-values are made bold
Results of the logistic regression analysis with infectious agents as dependent variables according to different age groups
| Infectious Agents | Age groups (in months) | |||||
|---|---|---|---|---|---|---|
| 1–3 | 4–11 | 12–23 | 24–35 | 36–47 | 48–60 | |
| Unidentified group I: OR (95% CI); | 1.343 (0.656–2.753); 0.420 | 0.819 (0.471–1.425); 0.480 | 0.931 (0.534–1.623); 0.801 | 1.252 (0.677–2.314); 0.474 | 0.966 (0.480–1.944); 0.922 | 1.000 |
| 1.782 (0.454–6.989); 0.407 | 2.865 (0.962–8.532); 0.059 | 3.024 (1.015–9.012); | 2.168 (0.661–7.113); 0.202 | 4.467 (1.355–14.726); | 1.000 | |
| 0.724 (0.339–1.547); 0.405 | 0.637 (0.356–1.137); 0.127 | 0.605 (0.336–1.087); 0.093 | 0.484 (0.247–0.952); | 0.390 (0.173–0.879); | 1.000 | |
| 2.800 (0.247–31.733); 0.406 | 5.060 (0.646–39.664); 0.123 | 3.006 (0.363–24.893); 0.307 | 7.241 (0.896–58.535); 0.063 | 9.800 (1.169–82.176); | 1.000 | |
| Mixed group V: OR (95% CI); | 0.328 (0.036–3.028); 0.326 | 1.654 (0.533–5.132); 0.383 | 1.387 (0.436–4.409); 0.579 | 0.356 (0.063–2.002); 0.241 | 0.299 (0.032–2.754); 0.287 | 1.000 |
Significant p-values are made bold